Abstract
Despite recent advances, lung cancer remains a disease characterized by negativity, late diagnosis and poor outcomes. The need for advocacy in lung cancer is obvious. Recent years have seen an increase in the number of organizations and individuals advocating for improvements in this disease. With limited resources across all advocacy organizations, using external data and tools from other sources is welcome. Such a source is work undertaken by the Global Lung Cancer Coalition.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
